Shares in Novocure (NSDQ:NVCR) are on the rise again after the company today cited additional data from a pivotal trial evaluating its Optune device with temozolomide chemotherapy as a treatment for newly-diagnosed glioblastoma. Novocure’s Optune mobile device delivers low-intensity, intermediate frequency, alternating electric fields, called “tumor treating fields” or TTFields, to inhibit cancer cell replication. Get […]
Clinical Trials
7 medtech stories we missed this week: April 14, 2017
From FDA approvals to business expansion plans, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. BioTelemetry launches offer to acquire LifeWatch BioTelemetry and LifeWatch announced in an April 9 press release that the 2 companies have entered a transaction agreement that states BioTelemetry will launch a tender offer […]
Glaukos drops $6m on Dose Medical’s IOP sensor system
Glaukos (NYSE:GKOS) said today that it acquired Dose Medical‘s intraocular pressure sensor system assets for $5.5 million in cash, plus $9.5 million contingent upon development, clinical and regulatory milestones. The Dose Medical IOP sensor system includes a micro-invasive ocular implant that captures and stores a glaucoma patient’s short-interval IOP measurements. The system transmits data to […]
Report: Apple taps biomed engineers for stealthy diabetes program
Apple (NSDQ:AAPL) reportedly tapped a roster of biomedical engineers to develop non-invasive continuous glucose monitors in a secret program that was the brainchild of its late founder Steve Jobs. The 5-year-old effort has progressed to feasibility studies and Apple has also hired regulatory consultants, CNBC reported, citing “3 people familiar with the matter.” Jobs, who died […]
Simplify Medical launches pivotal study of MRI-conditional cervical disc
Simplify Medical said today that it launched a pivotal study of its eponymous cervical disc, which is designed to be safe during magnetic resonance imaging scans. Sunnyvale, Calif.-based Simplify said the implant is “optimized” for MRI scans in that it’s designed to eliminate the imaging artifact created by the metals used in some artificial disc replacements, using a […]
ConforMIS touts head-to-head study of iTotal PS knee and Zimmer Biomet’s NexGen PS
ConforMIS (NSDQ:CFMS) said today a head-to-head study comparing its iTotal PS customized knee implant with the off-the-shelf NexGen PS implant made by Zimmer Biomet (NYSE:ZBH) showed that its device more closely replicated the natural motion of a human knee. The 31-patient study, presented at the annual meeting of the British Assn. for Surgery of the Knee last month in […]
Adgero touts data for photodynamic drug-device combo
Adgero Biopharmaceuticals touted positive clinical data from studies of its late-stage photodynamic therapy platform for the treatment of cutaneous oncology indications, including unresectable metastatic breast cancer. The Princeton, N.J.-based company’s REM-001 therapy consists of a laser light source, a light delivery device and a photosensitizer drug. Get the full story at our sister site, Drug Delivery Business […]
Study: Deep brain stim shown to improve Tourettes symptoms
Deep brain stimulation procedures have been shown to reduce “tics,” or involuntary movements or outbursts, experienced by young adult individuals with Tourette’s syndrome, according to a new study. Results from the study were published last Friday in the Journal of Neurosurgery. Study researchers said the new data adds to a growing body which support DBS […]
Cytori wins FDA nod for cell therapy pilot trial
Cytori Therapeutics (NSDQ:CYTX) said today that the FDA approved an Investigational Device Exemption for a pilot trial of the company’s cell therapy in patients with thermal burn injury. The Relief trial is a part of Cytori’s ongoing R&D efforts under its contract with the U.S. Dept. of Health & Human Services’ Biomedical Advanced Research and […]
Canadian government, JDRF ink $30m partnership to support diabetes research
Canada’s Minister of Health, Jane Philpott, said today that the Canadian Institutes of Health Research inked a $30 million partnership with the Juvenile Diabetes Research Foundation to support clinical research for Type I diabetes. Both groups have agreed to invest $15 million to the deal. “The government of Canada recognizes the impact that Type I diabetes […]
Boston’s Brigham & Women’s joins InVivo Therapeutics Inspire study
InVivo Therapeutics (NSDQ:NVIV) said today Boston’s Brigham & Women’s Hospital joined the Inspire trial of the regenerative spinal scaffold it’s developing. The Cambridge, Mass.-based company is running a study of the neuro-spinal scaffold, an implant that’s designed to act as a physical substrate for nerve sprouting after acute spinal cord injuries. The 13th procedure in the trial, performed at […]